1Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, MD.
2Division of Pulmonary, Allergy, and Critical Care, Emory University, Atlanta, GA.
3Division of Pulmonary and Critical Care, Intermountain Medical Center and University of Utah, Salt Lake City, UT.
4Division of Pulmonary and Critical Care, University of Medicine and Dentistry of New Jersey, Newark, NJ.
5Division of Pulmonary, Critical Care, and Environmental Medicine, University of Missouri-Columbia, Columbia, MO.
6Division of Pulmonary and Critical Care, Meharry Medical College, Nashville, TN.
7Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN.
8Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
9Department of Surgical Critical Care, University of Maryland, Baltimore, MD.
10Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Ohio State University, Cleveland, OH.
11Division of Acute Care Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
12Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
13Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MA.
14Division of Pulmonary and Critical Care Medicine, University of Rochester, Rochester, NY.
15INOVA Fairfax Hospital, Falls Church, VA.
16Suburban Hospital, Bethesda, MD.
17Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT.
18Department of Anesthesia, Beth Israel Deaconess Medical Center, Boston, MA.
* See also p. 463.
The list of United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study Investigators can be found in Appendix 1.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Checkley was supported by a Pathway to Independence Award (R00 HL096955) from the National Heart, Lung and Blood Institute, National Institutes of Health (NIH). He received support for article research from the NIH. Dr. Martin has board membership with Cumberland Pharmaceuticals and Pulsion Medical Systems (no money paid). He consulted for AstraZeneca and Agennix. He was supported in part by R01 FD003440, P50 AA013757, and UL1 TR000454. His institution received grant support from NIH, FDA, Baxter Healthcare, and Abbott. Dr. Brown received support for article research from the NIH. His institution received grant support from NIH (K23GM094465). Dr. Girard lectured for Hospira (honoraria for nonpromotional 78 presentation). He received support for travel from Hospira. His institution received grant support from NIH. Dr. Rice consulted for GlaxoSmithSkline, LLC and Asiva Pharma, LLC. Dr. Johnson consulted for Becton-Dickenson and Medimmune. He is employed by the American College of Surgeons and Banner Health. Dr. O’Brien serves as Chairman of Board of Sepsis Alliance and is the Vice-Chair of Quality Improvement Committee of ACCP (neither provide any financial reimbursement). Dr. Pastores lectured for the American Physician Institute and the International Multiprofessional critical care review course (Korea and Saudi Arabia). He spoke at the Medical Grand Rounds Conferences for New York Downtown Hospital, Coney Island Hospital, and Pinnacle Healthcare System. His institution received grant support from Spectral Diagnostics (is the principal investigator at MSKCC for an ongoing phase 3 septic shock clinical trial) and Altor Biosciences (was the principal investigator at MSKCC for a phase 2 sepsis-induced ARDS clinical trial in 2011–2012). Dr. Patil received support for travel from the FTCTS-Care Foundation and has stock options with Microsoft, GE, Intel, Walmart, and Bank of America. Her institution received research grant support from NIH/NIAID and from Canyon Pharmaceuticals. Dr. Sevransky was supported in part by K23 GM071399. He received support for article research from the NIH. His institution received grant support from NIGMS and Abott Labs. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
